Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00428038 · ClinicalTrials.gov registry record
Assessment of the Pulmonary Diffusion Capacity in Healthy Infants and Infants With Chronic Lung Disease
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 68
- Enrollment target
NCT00428038: Completed study, sponsored by Indiana University.
NCT00428038 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 68 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00428038 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 68 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate how easily gas can be taken up by the lung. We are comparing infants born premature \<32 weeks gestation to infants born full term \>37 weeks. We hope to evaluate the differences between the two groups in order to learn more about premature lung growth and development.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2004-02 |
| Est. Completion | 2008-12 |
What the finished NCT00428038 record still lists
NCT00428038 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 68 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00428038 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00428038 about?
NCT00428038 is a clinical study titled "Assessment of the Pulmonary Diffusion Capacity in Healthy Infants and Infants With Chronic Lung Disease". The purpose of this study is to evaluate how easily gas can be taken up by the lung. We are comparing infants born premature \<32 weeks gestation to infants born full term \>37 weeks. We hope to evaluate the differences between the two groups in order to learn more about premature lung growth and de...
What is the current status of trial NCT00428038?
This trial is currently completed. The enrollment target is 68 participants. The study started on 2004-02. Estimated completion is 2008-12.
Who is sponsoring clinical trial NCT00428038?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia